SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-12-000042
Filing Date
2012-05-21
Accepted
2012-05-21 14:25:54
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 OXIS 10-Q MARCH 31, 2012 oxis10qq12012.htm 10-Q 513802
2 FORM OF 8% CONVERTIBLE DEBENTURE ex1020debenture.htm EX-10.20 150003
3 FORM OF SERIES A WARRANT ISSUED WITH 8% CONVERTIBLE DEBENTURE ex1021seriesa.htm EX-10.21 109507
4 FORM OF SERIES B WARRANT ISSUED WITH 8% CONVERTIBLE DEBENTURE ex1022seriesb.htm EX-10.22 109236
5 STANDSTILL AND FORBEARANCE AGREEMENT DATED AS OF MAY 15, 2012 ex1023standstill.htm EX-10.23 56941
6 EXHIBIT 31.1 ex311.htm EX-31.1 13744
7 EXHIBIT 32.1 ex321.htm EX-32.1 6224
  Complete submission text file 0001513160-12-000042.txt   2715703

Data Files

Seq Description Document Type Size
8 EX-101.INS oxis-20120331.xml EX-101.INS 348631
9 EX-101.SCH oxis-20120331.xsd EX-101.SCH 12899
10 EX-101.CAL oxis-20120331_cal.xml EX-101.CAL 25761
11 EX-101.DEF oxis-20120331_def.xml EX-101.DEF 12953
12 EX-101.LAB oxis-20120331_lab.xml EX-101.LAB 92710
13 EX-101.PRE oxis-20120331_pre.xml EX-101.PRE 59480
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 12857932
SIC: 2834 Pharmaceutical Preparations